Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. (Q37222191)
Jump to navigation
Jump to search
scientific article published on 29 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. |
scientific article published on 29 June 2016 |
Statements
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer (English)
Rosemary Millen
Jordane Malaterre
Ryan S Cross
Sandra Carpinteri
Ben Tran
Peter Gibbs
Nikolajs Zeps
Paul Waring
1 reference